TERN — Terns Pharmaceuticals Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-PSQ Holdings, Core Scientific, Keros
U.S. STOCKS ON THE MOVE-BlackRock, Terns Pharma, PSQ Holdings
Terns Pharma rises on early data for blood cancer drug
Brief: Terns Pharmaceuticals Reports Inducement Grant To New Employee
Terns Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Terns Pharmaceuticals Q3 Net Income USD -21.945 Million Vs. IBES Estimate USD -25.7 Million
Brief: Terns Announces Pricing Of Upsized $150.15 Mln Public Offering
Terns Pharma extends rally after promising obesity drug study
U.S. RESEARCH ROUNDUP-Apple, Fedex, Vaxcyte
Brief: Terns Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Teekay, Brenmiller Energy, JetBlue
U.S. STOCKS ON THE MOVE-Teekay, Brenmiller Energy, JetBlue
U.S. STOCKS ON THE MOVE-Western Alliance Bancorp, Terns Pharma, Rezolute
Terns Pharma rises as obesity drug cuts weight by 4.9% in early study
Terns Pharmaceuticals' oral obesity drug cuts weight by 4.9% in early study (updated)
Terns Pharmaceuticals' obesity drug cuts weight by 4.9% in early study
Terns Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Terns Pharmaceuticals Q2 Net Income USD -22.736 Million Vs. IBES Estimate USD -26 Million
Terns Pharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview